Skip to main content
Ocumension Therapeutics logo

Ocumension Therapeutics — Investor Relations & Filings

Ticker · 1477 ISIN · KYG674111011 LEI · 5493000USURI3SIL4Z85 HKEX Manufacturing
Open in API
Filings indexed 459 across all filing types
Latest filing 2024-11-14 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 1477

About Ocumension Therapeutics

http://www.ocumension.com

Ocumension Therapeutics is an ophthalmic pharmaceutical platform company dedicated to the research, development, and commercialization of first-in-class or best-in-class therapeutics. The company focuses on providing comprehensive treatment solutions for Chinese patients suffering from ocular diseases. Ocumension has established a complete ophthalmic drug product line, currently holding 20 drug assets covering both anterior and posterior segments of the eye. Its portfolio addresses major conditions such as chronic non-infectious uveitis, infective and allergic conjunctivitis, and diabetic macular edema. The company employs a strategy combining continuous scientific innovation, independent R&D, and strategic alliances to sustain the supply of innovative products across the ophthalmology field.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed data on share repurchases, including dates, prices, and quantities. The document includes confirmations of compliance with listing rules and regulatory requirements. It is a regulatory disclosure about share repurchase activity and changes in capital structure, not a full financial report or earnings release. Therefore, it fits the category of 'Transaction in Own Shares' (POS), which covers company buybacks or sales of its own shares.
2024-11-14 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed data on share repurchases, including dates, prices, and quantities. The document is a regulatory disclosure about share repurchase activity and changes in share capital, not a financial report or earnings release. It fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2024-11-13 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed data on share repurchases, including dates, prices, and quantities. The document includes confirmations of compliance with listing rules and regulatory requirements. It is a regulatory disclosure about share repurchase activity rather than a financial report or earnings release. This fits the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares. The document length and detail confirm it is not a brief announcement but a formal report of share transactions by the company.
2024-11-12 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed data on share repurchases, including dates, prices, and quantities. The document also includes confirmations regarding compliance with listing rules and legal requirements. This type of disclosure is a regulatory announcement about share repurchases and treasury share transactions, not a full financial report or earnings release. It fits the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares.
2024-11-11 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed data on share repurchases, treasury shares, and confirmations of compliance with listing rules. The content is regulatory in nature, focused on disclosure of share transactions rather than financial performance or management commentary. It is not a full financial report, earnings release, or management discussion. The document is a formal regulatory disclosure about share repurchases and treasury share changes, fitting the category of Transaction in Own Shares (POS).
2024-11-08 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed data on share repurchases, including dates, prices, and quantities. The document includes confirmations that the repurchases were authorized and compliant with listing rules. This type of document is a regulatory disclosure about share repurchases and treasury share transactions, not a financial report or earnings release. It fits the definition of a 'Transaction in Own Shares' filing, which reports the company's buyback or sale of its own shares.
2024-11-07 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.